Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health Corp. is investing in a young chain of health clinics, and may be looking to acquire another.

CVS eyes next-generation health clinics after Amazon's move for One Medical

Abbott Labs

Medtronic

With products and services that many of us can't live without, these businesses are poised to deliver steadily rising dividend payouts.

3 Reliable Dividend Stocks You Can Buy With $600

Aflac

Con Ed

W.W. Grainger

Johnson & Johnson

McDonald's

Pfizer

Shell PLC

T. Rowe Price Group

Vanguard High Dividend Yield ETF

A decade of investing is snowballing on its own, but we keep investing as much as we can. In December, we (my wife and I) received a dividend income total of $8,110.03.

Dividend Income Summary: Lanny's December 2022 Summary

Comcast

These stocks have payout ratios of around 90%, suggesting that their dividend payments may not be sustainable.

Are These 2 Dividend Stocks in Danger of Cutting Their Payouts?

AbbVie

Medical Properties Trust

Steadily growing dividend payments from these stocks could do wonders for your passive income portfolio down the road.

3 Outstanding Dividend Growth Stocks to Buy for 2023

Apple

Automatic Data Processing

Ameriprise Financial

A. O. Smith

Broadcom

Best Buy

Blackrock Inc

Blackstone Group

Cardinal Health

Cincinnati Financial

CME Group

Diamond Hill Investment Group

Duke Energy

Enterprise Products Partners

Fortune Brands Innovations Inc

Healthcare Services Group

Home Depot

Honeywell

Intercontinental Exchange

Intel

2022 was another fantastic year for dividend growth, with my income increasing by over 13%. I recount every sale made during the year and the replacement purchases.

My Dividend Growth Portfolio - Final 2022 Recap

Amgen

Air Products and Chemicals

Bristol-Myers

ConocoPhillips

Review of the current holdings and sectors in the portfolio, and how it has changed over the years. Income projections for 2023, and potential pitfalls.

2023 Dividend Growth Portfolio Review And Look Ahead

Becton, Dickinson and Co.

The two healthcare companies easily outdid the S&P 500 this year.

2 Medical Stocks to Watch Heading Into 2023

Nothing is more reassuring to an income investor than a boost to the dividend.

2 Unstoppable Dividend Growth Stocks to Buy in 2023 and Beyond

Ally Financial

The investment bank analysts who follow these stocks expect impressive gains in addition to their quarterly dividend payments.

3 Dividend Stocks to Buy That Could Gain 26% to 37% in 2023, According to Wall Street

Amazon

FedEx

Alphabet

Mondelez

Microsoft

Raytheon Technologies

Truist Financial

Lower lows could be ahead for investors. Here are Michael Farr's picks for the new year.

Michael Farr: These are 2023's top stock picks for what could be a rocky year

We believe that CVS Health stock (NYSE: CVS) is currently a better pick over its peer Cigna stock (NYSE: CI), given its comparatively lower valuation of 0.4x trailing revenues vs. 0.6x for Cigna﻿CI﻿.

Here's Why CVS Health Stock Is A Better Pick Over Its Industry Peer

Boeing

Morgan Stanley

Are these the best blue chip stocks to buy in the stock market right now?

Best Blue Chip Stocks To Buy Right Now? 3 In Focus

WOONSOCKET, R.I. , Dec. 22, 2022 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that President and CEO Karen S.

CVS Health to present at the 41st Annual J.P. Morgan Healthcare Conference

Toronto-Dominion Bank

These are safe long-term investments to hold that will also provide you with reliable dividend income over the years.

3 High-Yielding Dividend Stocks You Can Buy and Forget About

CVS Health Corp. ( CVS , Financial) announced that it was increasing its quarterly dividend payment by 10% to 60.5 cents per share for the upcoming Feb. 1, 2023 payment date. This marks the second straight December that the company has announced a 10% increase after CVS had held its dividend steady for 20 quarters in a row.

CVS Health Posts Another Double-Digit Dividend Increase

These companies have histories of rapid payout increases and the means to continue them.

2 Exceptional Dividend Growth Stocks to Buy Now

Walgreens

Pharmacy chains CVS Health Corp. and Walgreens Boots Alliance Inc. limited purchase of children's pain drugs as they face supply constraints and high demand with the United States experiencing one of the worst flu season in a decade.

CVS, Walgreens limit purchase of children's pain medicines

AllianceBernstein Hld

Arbor Realty Trust

Ares Capital

March-April, 2022, UBS, Kiplinger, and Barron's analysts and reporters combined to list five sets of stocks sorted as: “Inflation Busters for 2022.” Those five articles revealed 48 equities, with 43 paying-dividends.

Buy 10 December Inflation-Busting Dividend Dogs

News for CVS Health Stock (CVS)